| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |